HeartBeam (BEAT) Amortization of Deferred Charges (2021)

HeartBeam (BEAT) reported Amortization of Deferred Charges of $45000.0 for Q4 2021, down 47.67% on a QoQ basis from $86000.0 in Q3 2021.

HeartBeam (BEAT) has 1 years of Amortization of Deferred Charges data on file, last reported at $45000.0 in Q4 2021.

  • Quarterly Amortization of Deferred Charges changed N/A year-over-year to $45000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $45000.0 (down 80.69% YoY) and the FY2021 annual result came in at $278000.0, up 892.86% from the prior year.
  • Amortization of Deferred Charges slipped to $45000.0 in Q4 2021 per BEAT's latest filing, from $86000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $86000.0 in Q3 2021 and bottomed at $45000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 HeartBeam 5.16 Mn 5.16 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2021 45,000.00
Dec 31, 2021 45,000.00
Sep 30, 2021 86,000.00
Sep 30, 2021 86,000.00
Jun 30, 2021 78,000.00
Jun 30, 2021 78,000.00
Mar 31, 2021 69,000.00
Mar 31, 2021 69,000.00